Biotech stocks are high-risk ... the stock prices of the respective companies in an appreciable manner. 1. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Date: Tuesday, June 25 Catalyst: Discussion ...

Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals ... The median Dicerna employee made $311,375 last year. The biotech was able to grow its headcount by 63% last year, according to financial ...

(RTTNews) - Arrowhead Pharmaceuticals (ARWR), a clinical-stage biotech company, announced, on Tuesday, that it has entered into a global licensing and collaboration agreement with Sarepta ...

B. Riley upped their FY2025 earnings per share estimates for shares of Arrowhead Pharmaceuticals in a report issued on ...

And while Wood said the pharma still isn’t interested in joining the overcrowded obesity landscape, GSK is considering ways ...

Sarepta Therapeutics’ Duchenne muscular dystrophy therapy Elevidys handily beat analysts’ expectations in the fourth quarter ...

Riley issued their Q2 2025 EPS estimates for shares of Arrowhead Pharmaceuticals in a report released on Thursday, December 12th. B. Riley analyst M. Mamtani forecasts that the biotechnology ...